Literature DB >> 21376537

Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.

Elaine Weiner, Alison Buchholz, Agnes Coffay, Fang Liu, Robert P McMahon, Robert W Buchanan, Deanna L Kelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21376537      PMCID： PMC3691956          DOI： 10.1016/j.schres.2011.02.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  13 in total

1.  Exacerbation of schizophrenia by varenicline.

Authors:  Robert Freedman
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

2.  Varenicline treatment for smokers with schizophrenia: a case series.

Authors:  A Eden Evins; Donald C Goff
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

3.  Varenicline efficacy and tolerability in a subject with schizophrenia.

Authors:  S Hossein Fatemi
Journal:  Schizophr Res       Date:  2008-06-24       Impact factor: 4.939

4.  Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked.

Authors:  J E Henningfield; M L Stitzer; R R Griffiths
Journal:  Addict Behav       Date:  1980       Impact factor: 3.913

5.  Cigarette smoking and mortality risk in people with schizophrenia.

Authors:  Deanna L Kelly; Robert P McMahon; Heidi J Wehring; Fang Liu; Kristen M Mackowick; Douglas L Boggs; Kimberly R Warren; Stephanie Feldman; Joo-Cheol Shim; Raymond C Love; Lisa Dixon
Journal:  Schizophr Bull       Date:  2009-12-17       Impact factor: 9.306

6.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

7.  Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Authors:  John A Stapleton; Lucy Watson; Lucy I Spirling; Robert Smith; Andrea Milbrandt; Marina Ratcliffe; Gay Sutherland
Journal:  Addiction       Date:  2007-11-19       Impact factor: 6.526

8.  To whom do psychiatrists offer smoking-cessation counseling?

Authors:  Seth Himelhoch; Gail Daumit
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

Review 9.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

10.  Assessing depression in schizophrenia: the Calgary Depression Scale.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Br J Psychiatry Suppl       Date:  1993-12
View more
  25 in total

1.  Interventions for the metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

2.  Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.

Authors:  Karolina Kozak; Tony P George
Journal:  Expert Opin Pharmacother       Date:  2020-02-03       Impact factor: 3.889

Review 3.  Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.

Authors:  A Eden Evins; Corinne Cather; Alexandra Laffer
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

Review 4.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

5.  Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.

Authors:  Randi M Schuster; Corinne Cather; Gladys N Pachas; Haiyue Zhang; Kristina M Cieslak; Susanne S Hoeppner; David Schoenfeld; A Eden Evins
Journal:  Addict Behav       Date:  2017-02-24       Impact factor: 3.913

Review 6.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

Review 7.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 8.  Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Authors:  Henri-Jean Aubin; Amandine Luquiens; Ivan Berlin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

9.  Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.

Authors:  Gladys N Pachas; Corinne Cather; Sarah A Pratt; Bettina Hoeppner; Johanna Nino; Sara V Carlini; Eric D Achtyes; Harry Lando; Kim T Mueser; Nancy A Rigotti; Donald C Goff; A Eden Evins
Journal:  J Dual Diagn       Date:  2012-05-11

Review 10.  Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.

Authors:  Emmert Roberts; A Eden Evins; Ann McNeill; Debbie Robson
Journal:  Addiction       Date:  2016-01-19       Impact factor: 6.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.